Buy wegovy online in australia from Onlinepharmaustralia. Wegovy injection treatment is a once-weekly prescription treatment containing semaglutide. In Australia, Wegovy is registered for chronic weight management alongside a reduced-energy diet and increased physical activity in eligible adults, and it has additional approved indications for certain adolescents and specific medical conditions.
Unlike tablets, Wegovy is administered as a subcutaneous injection. The treatment is normally started at a low dose and gradually increased so the body can adjust to semaglutide.
This guide explains how Wegovy injections work, where they are administered, how dosing generally progresses, what happens if you miss an injection, how Wegovy should be stored and which symptoms require medical attention.
What Is Wegovy Injection Treatment?
Wegovy contains semaglutide, a medicine that belongs to the GLP-1 receptor agonist class.
Wegovy injection treatment is designed for ongoing weight management rather than as a short-term weight-loss injection. It is used together with dietary changes and increased physical activity when prescribed for weight management.
In Australia, Wegovy is a Schedule 4 prescription medicine, meaning a prescription is required to obtain it from a pharmacist.
The medicine is administered under the skin rather than into a vein or muscle.
How Does the Wegovy Injection Work?
Semaglutide acts on GLP-1 receptors in the body.
One important effect is that it can influence appetite and food intake. This can help some people feel fuller for longer and consume less food.
Wegovy treatment is therefore intended to support sustained changes in body weight when combined with an appropriate diet and physical activity plan.
The response varies between individuals. A healthcare professional should assess progress throughout treatment rather than relying on a fixed expectation of weight loss.
How Often Is the Wegovy Injection Taken?
Wegovy is administered once a week.
It can generally be injected at any time of day and with or without food. The injection should be taken on the scheduled day each week.
The weekly dosing schedule can make treatment easier to incorporate into a regular routine compared with medicines that need to be taken every day.
If your healthcare professional changes your dosing day, there should be at least 72 hours between two doses.
Where Do You Inject Wegovy?
Wegovy is administered by subcutaneous injection.
The approved injection sites include:
- Abdomen
- Thigh
- Upper arm
The injection site can be changed without changing the dose. Wegovy should not be injected into a vein or muscle.
Always follow the instructions supplied with your specific Wegovy device. Your doctor, pharmacist or other healthcare professional can also show you how to use the pen correctly.
Wegovy Injection Dose Schedule
Wegovy treatment normally begins with a lower dose and increases gradually.
The Australian Product Information describes the following dose-escalation schedule:
| Treatment period | Weekly Wegovy dose |
|---|---|
| Weeks 1–4 | 0.25 mg |
| Weeks 5–8 | 0.5 mg |
| Weeks 9–12 | 1 mg |
| Weeks 13–16 | 1.7 mg |
| Maintenance | 2.4 mg |
The gradual increase is intended to help reduce gastrointestinal symptoms.
Not everyone will progress through the schedule in exactly the same way. If significant gastrointestinal symptoms occur, dose escalation may need to be delayed. If the 2.4 mg dose is not tolerated, the Australian Product Information allows for a temporary reduction to 1.7 mg before attempting to increase again.
Your prescribed dose should therefore be determined by your healthcare professional.
How to Use a Wegovy Injection
If you have been prescribed Wegovy and instructed to administer it yourself, carefully follow the instructions supplied with your particular pen.
In general, the process involves:
1. Check your prescribed dose
Make sure the pen corresponds to the dose prescribed by your healthcare professional.
Do not change the dose yourself.
2. Choose an injection site
Wegovy can be administered into the abdomen, thigh or upper arm.
Rotating injection sites can help avoid repeatedly using exactly the same area.
3. Prepare the pen
Follow the manufacturer’s instructions for preparing the pen and administering the dose.
4. Administer the injection under the skin
Wegovy is a subcutaneous injection. It should not be injected into a muscle or vein.
5. Complete the injection
The Australian Product Information states that the pen should be held firmly against the skin until the yellow indicator has stopped moving. The injection takes approximately 5–10 seconds.
6. Dispose of the pen appropriately
Follow local instructions for safe disposal of the used device.
The pen should only be used by the patient it was prescribed for.
If you are unsure how to use your Wegovy pen, ask your pharmacist or healthcare professional for a demonstration rather than relying on an online video or another person’s instructions.
What Happens If You Miss a Wegovy Injection?
Missing a weekly dose does not necessarily mean you should take two injections.
The Australian Product Information states that if a dose is missed, it should be administered as soon as possible within 5 days.
If more than 5 days have passed, the missed dose should be skipped and the next dose taken on the normal scheduled day.
After that, the regular weekly schedule can be resumed. If multiple doses have been missed, your healthcare professional may consider whether treatment should be restarted at a lower dose.
Never take an extra dose to compensate for a missed injection unless specifically instructed by your healthcare professional.
What Are the Common Side Effects of Wegovy Injections?
Because Wegovy affects the gastrointestinal system, digestive symptoms are among the commonly reported effects.
These may include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
- Indigestion
Some gastrointestinal symptoms may be more noticeable when the dose is increased.
The TGA updated the Australian Product Information for semaglutide medicines in June 2026 to include additional information about gastrointestinal effects and dehydration, particularly noting that people with gastroparesis may experience more serious or severe gastrointestinal effects.
Other adverse effects and warnings are described in the official Product Information and Consumer Medicine Information.
When Should You Seek Medical Advice?
Not every side effect requires emergency treatment, but some symptoms should be discussed promptly with a healthcare professional.
Seek medical advice if you experience severe or persistent vomiting, diarrhoea, dehydration or significant abdominal symptoms.
You should also discuss any unusual changes in vision with a healthcare professional. The TGA’s June 2026 safety update added information about non-arteritic anterior ischaemic optic neuropathy (NAION) to the semaglutide Product Information.
Gallbladder problems, including cholecystitis, are also included among the updated adverse-effect information.
This is one reason regular clinical follow-up is important during Wegovy treatment.
How Should Wegovy Be Stored?
Wegovy should generally be stored in a refrigerator at 2°C to 8°C, protected from light and not frozen. Healthdirect lists Wegovy as requiring refrigeration and states that it should not be frozen.
Storage requirements can vary according to the specific product and device presentation, so always check the Consumer Medicine Information supplied with your medicine.
If you believe your Wegovy has been frozen, exposed to inappropriate temperatures or otherwise stored incorrectly, speak with a pharmacist before using it.
Can Wegovy Injection Treatment Be Used During Pregnancy?
Wegovy is not a treatment that should be started or continued during pregnancy without medical advice.
If you are pregnant, planning a pregnancy or think you may be pregnant, speak with your doctor or pharmacist about semaglutide.
Healthdirect specifically recommends discussing semaglutide use with a doctor or pharmacist when pregnant or planning pregnancy.
Do not make changes to prescription treatment based solely on information from an online article.
Who May Be Prescribed Wegovy Injection Treatment?
For chronic weight management in adults, the Australian indication includes people with an initial:
- BMI of 30 kg/m² or higher, or
- BMI of 27 kg/m² to less than 30 kg/m² with at least one weight-related comorbidity.
Wegovy is used alongside a reduced-energy diet and increased physical activity.
However, meeting a BMI threshold does not automatically mean that Wegovy is appropriate for an individual.
A clinician should consider medical history, current medicines, weight-management history, existing health conditions, treatment goals and other relevant factors before prescribing.
Wegovy also has a separate Australian indication for certain adolescents aged 12 years and above with obesity and an initial body weight above 60 kg.
Injection Treatment and Medical Follow-Up
should not be viewed simply as an injection that is taken indefinitely without monitoring.
Follow-up can help a healthcare professional assess:
- Changes in body weight
- Treatment response
- Side effects
- Tolerance of dose increases
- Other medicines being taken
- Changes in health conditions
- Whether the current treatment plan remains appropriate
This is particularly important when doses are being increased.
If you develop significant gastrointestinal symptoms or other concerning symptoms, your healthcare professional may need to review your treatment before the next dose increase.
Can Wegovy Be Used With Other GLP-1 Medicines?
Wegovy should not be combined with another GLP-1 receptor agonist unless specifically directed as part of appropriate medical management.
The Australian Product Information specifically states that Wegovy should not be used together with other GLP-1 receptor agonist products.
This is important because several medicines used for diabetes and weight management belong to the same broader class.
Always tell your prescriber about all prescription medicines, over-the-counter medicines and other treatments you are taking.
Wegovy Injection Treatment vs Wegovy Tablets
Wegovy is different from oral semaglutide products because it is administered by subcutaneous injection.
The injection allows semaglutide to be delivered on a weekly schedule.
The correct form of semaglutide depends on the medicine prescribed for your particular condition. Wegovy should not be substituted with another semaglutide product without professional medical advice.
How Long Does Wegovy Injection Treatment Last?
There is no single treatment duration that applies to every patient.
Wegovy is registered for chronic weight management, including weight loss and weight maintenance, rather than simply a short course of treatment.
The appropriate duration depends on factors such as treatment response, tolerability, health goals and the ongoing assessment of benefits and risks.
If you are considering stopping Wegovy, discuss this with your healthcare professional first.
Wegovy Injection Treatment in Australia: Prescription Requirements
Wegovy is a prescription-only medicine in Australia.
Healthdirect lists Wegovy as a Schedule 4 prescription medicine and states that a prescription is required.
A legitimate treatment pathway should involve an appropriate clinical assessment before a prescription is issued.
Be cautious of websites offering prescription medicines without appropriate medical assessment or making unrealistic claims about guaranteed weight loss.
The TGA maintains information about registered Wegovy products and approved indications in Australia.
Frequently Asked Questions About Wegovy Injection Treatment
How often do you inject Wegovy?
Wegovy is normally injected once a week.
Where can Wegovy be injected?
The approved subcutaneous injection sites include the abdomen, thigh and upper arm.
Can Wegovy be injected into a muscle?
No. Wegovy is intended for subcutaneous administration and should not be injected intramuscularly or intravenously.
What happens if I forget my Wegovy injection?
If the missed dose is within 5 days, the Australian Product Information states that it should be administered as soon as possible. If more than 5 days have passed, skip the dose and take the next dose on the regular day.
Can I change my Wegovy injection day?
The weekly dosing day can be changed when necessary, provided there are at least 72 hours between two doses.
Does Wegovy injection treatment work for everyone?
Individual responses vary. Wegovy is intended to be used as part of a broader weight-management approach that includes dietary and physical-activity measures.
Can I increase my Wegovy dose faster?
Do not increase the dose faster than prescribed. The Australian Product Information describes gradual dose escalation and allows treatment to be adjusted when gastrointestinal symptoms are significant.
Do I need a prescription for Wegovy in Australia?
Yes. Wegovy is listed by Healthdirect as a Schedule 4 prescription medicine.
Is Wegovy injection treatment the same as Ozempic?
Both contain semaglutide, but they are different registered products with different approved indications and product presentations. They should not be treated as interchangeable medicines without advice from a healthcare professional.
Final Thoughts
Wegovy injection treatment provides a once-weekly way to administer semaglutide for eligible patients. Treatment normally begins at a low dose and progresses gradually, with medical follow-up used to assess tolerance, side effects and treatment response.
Correct injection technique, appropriate storage and adherence to the prescribed schedule are important parts of treatment.
Because Wegovy is a prescription medicine, treatment should begin with an appropriate medical assessment rather than an online purchase based solely on weight or BMI.
If you are considering Wegovy for weight management, speak with a qualified healthcare professional about whether it is appropriate for your individual circumstances.
Medical Information Notice: This article is provided for general educational purposes and does not replace medical advice, diagnosis or treatment. Always follow the prescribing instructions and Consumer Medicine Information supplied with your Wegovy product. Australian product information can change as new safety information becomes available. The TGA recorded safety-related updates for semaglutide medicines in June 2026, so patients and healthcare professionals should refer to current official information.